↓ Skip to main content

Creatine and Creatine Kinase in Health and Disease

Overview of attention for book
Cover of 'Creatine and Creatine Kinase in Health and Disease'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Introduction – Creatine: Cheap Ergogenic Supplement with Great Potential for Health and Disease
  3. Altmetric Badge
    Chapter 2 Early Evolution of the Creatine Kinase Gene Family and the Capacity for Creatine Biosynthesis and Membrane Transport
  4. Altmetric Badge
    Chapter 3 The Creatine Kinase Phosphotransfer Network: Thermodynamic and Kinetic Considerations, the Impact of the Mitochondrial Outer Membrane and Modelling Approaches
  5. Altmetric Badge
    Chapter 4 Expression and Function of Agat, Gamt and CT1 in the Mammalian Brain
  6. Altmetric Badge
    Chapter 5 A Novel Relationship Between Creatine Transport at the Blood-Brain and Blood-Retinal Barriers, Creatine Biosynthesis, And its Use for Brain and Retinal Energy Homeostasis
  7. Altmetric Badge
    Chapter 6 Functional insights into the creatine transporter.
  8. Altmetric Badge
    Chapter 7 In Vivo Magnetic Resonance Spectroscopy of Transgenic Mice with Altered Expression of Guanidinoacetate Methyltransferase and Creatine Kinase Isoenzymes
  9. Altmetric Badge
    Chapter 8 Cerebral Creatine Deficiency Syndromes: Clinical Aspects, Treatment and Pathophysiology
  10. Altmetric Badge
    Chapter 9 Pre-Symptomatic Treatment of Creatine Biosynthesis Defects
  11. Altmetric Badge
    Chapter 10 Clinical use of creatine in neuromuscular and neurometabolic disorders.
  12. Altmetric Badge
    Chapter 11 The neuroprotective role of creatine.
  13. Altmetric Badge
    Chapter 12 Ergogenic Effects of Creatine in Sports and Rehabilitation
  14. Altmetric Badge
    Chapter 13 Pharmacokinetics of Creatine
  15. Altmetric Badge
    Chapter 14 Safety of creatine supplementation.
  16. Altmetric Badge
    Chapter 15 Creatine – its Chemical Synthesis, Chemistry, and Legal Status
  17. Altmetric Badge
    Chapter 16 Creatine and Creatine Kinase in Health and Disease – A Bright Future Ahead?
Attention for Chapter 10: Clinical use of creatine in neuromuscular and neurometabolic disorders.
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#46 of 388)
  • High Attention Score compared to outputs of the same age (90th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

blogs
1 blog
twitter
2 X users
facebook
1 Facebook page
wikipedia
1 Wikipedia page
video
1 YouTube creator

Readers on

mendeley
94 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Clinical use of creatine in neuromuscular and neurometabolic disorders.
Chapter number 10
Book title
Creatine and Creatine Kinase in Health and Disease
Published in
Sub cellular biochemistry, July 2008
DOI 10.1007/978-1-4020-6486-9_10
Pubmed ID
Book ISBNs
978-1-4020-6485-2, 978-1-4020-6486-9
Authors

Tarnopolsky MA, Mark A. Tarnopolsky, Tarnopolsky, Mark A.

Abstract

Many of the neuromuscular (e.g., muscular dystrophy) and neurometabolic (e.g., mitochondrial cytopathies) disorders share similar final common pathways of cellular dysfunction that may be favorably influenced by creatine monohydrate (CrM) supplementation. Studies using the mdx model of Duchenne muscular dystrophy have found evidence of enhanced mitochondrial function, reduced intra-cellular calcium and improved performance with CrM supplementation. Clinical trials in patients with Duchenne and Becker's muscular dystrophy have shown improved function, fat-free mass, and some evidence of improved bone health with CrM supplementation. In contrast, the improvements in function in myotonic dystrophy and inherited neuropathies (e.g., Charcot-Marie-Tooth) have not been significant. Some studies in patients with mitochondrial cytopathies have shown improved muscle endurance and body composition, yet other studies did not find significant improvements in patients with mitochondrial cytopathy. Lower-dose CrM supplementation in patients with McArdle's disease (myophosphorylase deficiency) improved exercise capacity, yet higher doses actually showed some indication of worsened function. Based upon known cellular pathologies, there are potential benefits from CrM supplementation in patients with steroid myopathy, inflammatory myopathy, myoadenylate deaminase deficiency, and fatty acid oxidation defects. Larger randomized control trials (RCT) using homogeneous patient groups and objective and clinically relevant outcome variables are needed to determine whether creatine supplementation will be of therapeutic benefit to patients with neuromuscular or neurometabolic disorders. Given the relatively low prevalence of some of the neuromuscular and neurometabolic disorders, it will be necessary to use surrogate markers of potential clinical efficacy including markers of oxidative stress, cellular energy charge, and gene expression patterns.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 94 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 1%
Germany 1 1%
Brazil 1 1%
Unknown 91 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 11 12%
Student > Master 11 12%
Student > Bachelor 10 11%
Researcher 8 9%
Student > Postgraduate 7 7%
Other 24 26%
Unknown 23 24%
Readers by discipline Count As %
Medicine and Dentistry 21 22%
Sports and Recreations 12 13%
Nursing and Health Professions 11 12%
Agricultural and Biological Sciences 7 7%
Biochemistry, Genetics and Molecular Biology 4 4%
Other 15 16%
Unknown 24 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 January 2024.
All research outputs
#3,026,815
of 25,169,746 outputs
Outputs from Sub cellular biochemistry
#46
of 388 outputs
Outputs of similar age
#9,253
of 95,500 outputs
Outputs of similar age from Sub cellular biochemistry
#5
of 6 outputs
Altmetric has tracked 25,169,746 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 388 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.9. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 95,500 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one.